Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Probiotics on Neonatal Hyperbilirubinemia
NCT02807246Completed
- Sponsor
- Karadeniz Technical University
- Start
- Dec 2014
- Primary completion
- Dec 2015
- Modality
- Live Biotherapeutic Products
01
Overview
Trial of Lactobacillus rhamnosus GG in neonatal hyperbilirubinemia (2 arms), sponsored by Karadeniz Technical University. Primary endpoint: Serum Bilirubin Levels at 10 days. Started Dec 2014; status: completed.
02
Drugs
Lactobacillus rhamnosus GG
03
Conditions
neonatal hyperbilirubinemia
Beyond the preview
Go deeper on NCT02807246.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02807246.